PetVivo Holdings, Inc. (PETV)
USD 0.61
(-3.48%)
USD 0.61
(-3.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 2.42 Million USD | 41.74% |
| 2023 | 1.71 Million USD | 18.97% |
| 2022 | 1.44 Million USD | -16.83% |
| 2021 | 1.73 Million USD | 11.13% |
| 2020 | 1.55 Million USD | 1.48% |
| 2019 | 1.53 Million USD | 7.33% |
| 2018 | 1.43 Million USD | 32.86% |
| 2017 | 1.07 Million USD | -27.16% |
| 2016 | 1.47 Million USD | 145.83% |
| 2015 | 601.6 Thousand USD | 25.56% |
| 2014 | 479.14 Thousand USD | 86.83% |
| 2013 | 256.46 Thousand USD | 43.3% |
| 2012 | 178.97 Thousand USD | 127.33% |
| 2011 | 78.72 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 3.07 Million USD | 13.78% |
| 2024 Q3 | 2.73 Million USD | -11.01% |
| 2024 Q4 | 2.42 Million USD | -11.17% |
| 2024 FY | 2.42 Million USD | 41.74% |
| 2024 Q1 | 2.7 Million USD | 57.59% |
| 2023 Q1 | 1.47 Million USD | 2.11% |
| 2023 Q2 | 1.48 Million USD | 1.11% |
| 2023 Q4 | 1.71 Million USD | -3.94% |
| 2023 FY | 1.71 Million USD | 18.97% |
| 2023 Q3 | 1.78 Million USD | 19.95% |
| 2022 Q4 | 1.44 Million USD | 15.6% |
| 2022 FY | 1.44 Million USD | -16.83% |
| 2022 Q2 | 1.36 Million USD | -17.77% |
| 2022 Q1 | 1.66 Million USD | -4.11% |
| 2022 Q3 | 1.24 Million USD | -8.76% |
| 2021 Q2 | 2.65 Million USD | 23.18% |
| 2021 Q3 | 1.56 Million USD | -41.18% |
| 2021 FY | 1.73 Million USD | 11.13% |
| 2021 Q1 | 2.15 Million USD | 38.22% |
| 2021 Q4 | 1.73 Million USD | 10.97% |
| 2020 Q4 | 1.55 Million USD | 10.72% |
| 2020 Q1 | 1.89 Million USD | 23.26% |
| 2020 Q2 | 1.44 Million USD | -23.56% |
| 2020 Q3 | 1.4 Million USD | -2.73% |
| 2020 FY | 1.55 Million USD | 1.48% |
| 2019 Q4 | 1.53 Million USD | 2.56% |
| 2019 Q3 | 1.49 Million USD | -5.48% |
| 2019 Q2 | 1.58 Million USD | 14.32% |
| 2019 Q1 | 1.38 Million USD | -3.15% |
| 2019 FY | 1.53 Million USD | 7.33% |
| 2018 FY | 1.43 Million USD | 32.86% |
| 2018 Q4 | 1.43 Million USD | -13.62% |
| 2018 Q3 | 1.65 Million USD | 0.57% |
| 2018 Q2 | 1.64 Million USD | 5.63% |
| 2018 Q1 | 1.55 Million USD | 44.79% |
| 2017 FY | 1.07 Million USD | -27.16% |
| 2017 Q1 | 1.59 Million USD | 8.16% |
| 2017 Q2 | 1.8 Million USD | 12.61% |
| 2017 Q3 | 2.01 Million USD | 11.8% |
| 2017 Q4 | 1.07 Million USD | -46.51% |
| 2016 Q1 | 2.75 Million USD | 358.33% |
| 2016 Q3 | 2.99 Million USD | 6.48% |
| 2016 Q2 | 2.81 Million USD | 1.95% |
| 2016 Q4 | 1.47 Million USD | -50.59% |
| 2016 FY | 1.47 Million USD | 145.83% |
| 2015 Q2 | 162.16 Thousand USD | -74.49% |
| 2015 Q1 | 635.69 Thousand USD | 32.67% |
| 2015 FY | 601.6 Thousand USD | 25.56% |
| 2015 Q4 | 601.6 Thousand USD | -72.31% |
| 2015 Q3 | 2.17 Million USD | 1239.86% |
| 2014 FY | 479.14 Thousand USD | 86.83% |
| 2014 Q3 | 1.06 Million USD | -8.52% |
| 2014 Q2 | 1.16 Million USD | 323.64% |
| 2014 Q1 | 274.62 Thousand USD | 7.08% |
| 2014 Q4 | 479.14 Thousand USD | -54.98% |
| 2013 FY | 256.46 Thousand USD | 43.3% |
| 2013 Q1 | 202.64 Thousand USD | 13.23% |
| 2013 Q3 | 253.45 Thousand USD | 8.16% |
| 2013 Q4 | 256.46 Thousand USD | 1.19% |
| 2013 Q2 | 234.33 Thousand USD | 15.64% |
| 2012 FY | 178.97 Thousand USD | 127.33% |
| 2012 Q2 | 112.22 Thousand USD | 0.0% |
| 2012 Q4 | 178.97 Thousand USD | 31.99% |
| 2012 Q3 | 135.59 Thousand USD | 20.82% |
| 2011 Q4 | 78.72 Thousand USD | 0.0% |
| 2011 FY | 78.72 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 95.26% |
| BrainsWay Ltd. | 15.31 Million USD | 84.137% |
| Cerus Corporation | 144.3 Million USD | 98.317% |
| Envoy Medical, Inc. | 9.4 Million USD | 74.162% |
| electroCore, Inc. | 8.94 Million USD | 72.842% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 54.525% |
| IceCure Medical Ltd | 4.24 Million USD | 42.8% |
| Inogen, Inc. | 121.38 Million USD | 97.999% |
| OrthoPediatrics Corp. | 72.56 Million USD | 96.652% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 91.788% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 23.654% |
| MaxCyte, Inc. | 36.1 Million USD | 93.272% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -31.462% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -471.222% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.256% |
| PAVmed Inc | 57.13 Million USD | 95.748% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 90.459% |
| RxSight, Inc. | 22.18 Million USD | 89.051% |
| Sight Sciences, Inc. | 46.43 Million USD | 94.768% |
| SI-BONE, Inc. | 61.05 Million USD | 96.021% |
| TELA Bio, Inc. | 59.16 Million USD | 95.894% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 97.868% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 76.458% |
| Acutus Medical, Inc. | 54.83 Million USD | 95.57% |
| Talis Biomedical Corporation | 29.22 Million USD | 91.687% |
| Spectral AI, Inc. | 12.4 Million USD | 80.41% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 89.499% |
| CVRx, Inc. | 39.28 Million USD | 93.816% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 79.685% |
| Bioventus Inc. | 589.79 Million USD | 99.588% |
| Venus Concept Inc. | 107.1 Million USD | 97.732% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 95.298% |
| LivaNova PLC | 1.15 Billion USD | 99.789% |
| 908 Devices Inc. | 37.49 Million USD | 93.52% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.655% |
| Nemaura Medical Inc. | 26.37 Million USD | 90.79% |
| NeuroPace, Inc. | 86.99 Million USD | 97.208% |
| LENSAR, Inc. | 22.4 Million USD | 89.159% |
| Apyx Medical Corporation | 52.31 Million USD | 95.357% |
| Cutera, Inc. | 518.12 Million USD | 99.531% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 91.717% |
| BioSig Technologies, Inc. | 4.68 Million USD | 48.147% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 95.838% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 88.695% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.889% |
| Axonics, Inc. | 82.35 Million USD | 97.05% |
| Outset Medical, Inc. | 190.91 Million USD | 98.728% |
| IRIDEX Corporation | 24.91 Million USD | 90.249% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 98.04% |
| IRadimed Corporation | 20.73 Million USD | 88.285% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -45.119% |
| INVO Bioscience, Inc. | 19.99 Million USD | 87.85% |
| Telesis Bio, Inc. | 40.87 Million USD | 94.056% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 94.044% |
| Varex Imaging Corporation | 668.6 Million USD | 99.637% |
| Quipt Home Medical Corp. | 136.29 Million USD | 98.218% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 31.99% |
| Pulmonx Corporation | 60.63 Million USD | 95.994% |
| Dynatronics Corporation | 11.78 Million USD | 79.378% |
| Modular Medical, Inc. | 2.27 Million USD | -6.923% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 40.224% |
| Semler Scientific, Inc. | 6.27 Million USD | 61.255% |
| InMode Ltd. | 75.91 Million USD | 96.8% |
| Bruker Corporation | 2.83 Billion USD | 99.914% |
| Cytosorbents Corporation | 29.98 Million USD | 91.898% |
| DexCom, Inc. | 4.19 Billion USD | 99.942% |
| Align Technology, Inc. | 2.45 Billion USD | 99.901% |
| Viveve Medical, Inc. | 10.84 Million USD | 77.604% |
| ZimVie Inc. | 795.85 Million USD | 99.695% |
| Movano Inc. | 5.97 Million USD | 59.322% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 97.678% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -471.222% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 79.685% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.62% |
| Profound Medical Corp. | 12.66 Million USD | 80.82% |
| Insulet Corporation | 1.85 Billion USD | 99.869% |
| enVVeno Medical Corporation | 2.43 Million USD | 0.234% |
| Surmodics, Inc. | 65.82 Million USD | 96.309% |
| iCAD, Inc. | 8 Million USD | 69.638% |
| Nuwellis, Inc. | 6.78 Million USD | 64.17% |
| Biotricity, Inc. | 35.91 Million USD | 93.237% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.911% |
| Aethlon Medical, Inc. | 2.47 Million USD | 2.031% |
| InspireMD, Inc. | 8.14 Million USD | 70.163% |
| PAVmed Inc. | 57.13 Million USD | 95.748% |
| BIOLASE, Inc. | 35.34 Million USD | 93.127% |
| Beyond Air, Inc. | 29.77 Million USD | 91.841% |
| FONAR Corporation | 57.45 Million USD | 95.772% |
| AxoGen, Inc. | 101.16 Million USD | 97.599% |
| Vivani Medical, Inc. | 25.03 Million USD | 90.297% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 97.233% |
| Inari Medical, Inc. | 209.32 Million USD | 98.839% |
| UFP Technologies, Inc. | 118.04 Million USD | 97.942% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 80.857% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -11.139% |
| Tenon Medical, Inc. | 5.56 Million USD | 56.362% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -36.554% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 86.224% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.923% |
| Sintx Technologies, Inc. | 6.59 Million USD | 63.153% |
| NanoVibronix, Inc. | 2.68 Million USD | 9.557% |
| Quanterix Corporation | 78.08 Million USD | 96.889% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 31.99% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 50.27% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.767% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.573% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 85.438% |
| NeuroMetrix, Inc. | 1.33 Million USD | -82.226% |
| Hyperfine, Inc. | 9.8 Million USD | 75.211% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.029% |
| Biomerica, Inc. | 2.66 Million USD | 8.776% |
| Bone Biologics Corporation | 831.4 Thousand USD | -192.193% |
| AVITA Medical, Inc. | 19.86 Million USD | 87.771% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -23.085% |
| Silk Road Medical, Inc | 114.15 Million USD | 97.872% |